{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-21-020884","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2021-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.318809+00:00","generated_at":"2026-06-28T16:10:03.666493+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ChromaDex director Tony Lau resigns; Champion River to nominate successor","bullets":["Tony Lau notified ChromaDex of his resignation from the Board and Compensation Committee on Oct 19, 2021; effective date not yet determined.","Resignation not due to any disagreement with the company; follows Lau's resignation from his position at Horizon Ventures.","Champion River Ventures, which nominated Lau, intends to nominate a replacement director under the 2017 Securities Purchase Agreement.","Lau's departure is unrelated to company operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-21-020884","json":"https://secwatch.observer/filing/0001628280-21-020884.json","markdown":"https://secwatch.observer/filing/0001628280-21-020884.md","text":"https://secwatch.observer/filing/0001628280-21-020884.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000162828021020884/0001628280-21-020884-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000162828021020884/cdxc-20211019.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:10:03.666493+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c2c6b66b11","claim":"Tony Lau resigned as director at Niagen Bioscience, Inc..","evidence_excerpt":"On October 19, 2021, Tony Lau notified ChromaDex Corporation (the “Company”) of his intention to resign from the board of directors of the Company (the “Board”) and as a member of the Compensation Committee of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828021020884/0001628280-21-020884-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}